Profound Medical Corp
TSX:PRN

Watchlist Manager
Profound Medical Corp Logo
Profound Medical Corp
TSX:PRN
Watchlist
Price: 6.93 CAD 2.67% Market Closed
Market Cap: 208.2m CAD

Intrinsic Value

PRN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one PRN stock under the Base Case scenario is 4.87 CAD. Compared to the current market price of 6.93 CAD, Profound Medical Corp is Overvalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PRN Intrinsic Value
4.87 CAD
Overvaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Profound Medical Corp

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PRN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PRN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Profound Medical Corp
TSX:PRN
CA
Health Care
Market Cap
208.2m CAD
IPO
Sep 24, 2014
CA
Health Care
Market Cap
208.2m CAD
IPO
Sep 24, 2014
Price
CA$false
EPS
$false
AI Assistant
AI Assistant
Ask me anything about Profound Medical Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Profound Medical Corp

Current Assets 69.1m
Cash & Short-Term Investments 54.9m
Receivables 7m
Other Current Assets 7.1m
Non-Current Assets 1.2m
PP&E 821k
Intangibles 261k
Other Non-Current Assets 87k
Efficiency

Free Cash Flow Analysis
Profound Medical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Profound Medical Corp

Revenue
10.7m USD
Cost of Revenue
-3.6m USD
Gross Profit
7m USD
Operating Expenses
-40.1m USD
Operating Income
-33.1m USD
Other Expenses
5.2m USD
Net Income
-27.8m USD
Fundamental Scores

PRN Profitability Score
Profitability Due Diligence

Profound Medical Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 1-Year Revenue Growth
Positive 3-Years Revenue Growth
26/100
Profitability
Score

Profound Medical Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

PRN Solvency Score
Solvency Due Diligence

Profound Medical Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Profound Medical Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRN Price Targets Summary
Profound Medical Corp

There are no price targets for PRN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Profound Medical Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for PRN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one PRN stock?

The intrinsic value of one PRN stock under the Base Case scenario is 4.87 CAD.

Is PRN stock undervalued or overvalued?

Compared to the current market price of 6.93 CAD, Profound Medical Corp is Overvalued by 30%.

Back to Top